SNOA - Sonoma Pharmaceuticals EPS misses by $0.66 misses on revenue July, 08 2019 04:09 PM Sonoma Pharmaceuticals Inc. Sonoma Pharmaceuticals (NASDAQ:SNOA): Q4 GAAP EPS of -$2.45 misses by $0.66.More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...